Presentation is loading. Please wait.

Presentation is loading. Please wait.

Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.

Similar presentations


Presentation on theme: "Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis."— Presentation transcript:

1 Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis Thomas L. Kash, Danny G. Winder

2 Introduction Neuropeptides (NPY) = potent neuromodulators in the CNS Involved in reward pathway  mediated via G-protein coupled receptors  released in a frequency dependent fashion  longer half-life of activity after release

3 Introduction Corticotropin Releasing Factor (CRF) involved in stress response  Mediated through the hypothalamus and the amygdala  Both pathways converge at the BNST

4 Introduction Life = Stress Repeated or severe stressors can produce behaviors such as post- traumatic stress disorder and generalized anxiety disorder BNST provides a substrate for interaction of CRF and NPY in regulating stress and anxiety

5 Introduction NPY Anxiety ↓ Reward pathway CRF Anxiety ↑ Stress response BNST acts as a scale to create a balance of CRF and NPY

6 Neves S, Ram P, Iyengar R. G protein pathways. Science 296, 1636-1639 (2002)

7 Introduction BNST expresses both NPY/YRs and CRF/CRFRs CeA releases CRF and GABA to the BNST Both CRF and NPY modulate GABAergic transmissions

8 Introduction Study GABAergic influence on ventrolateral region of the BNST vlBNST projects to the VTA (reward) and the PVN (stress)

9 Introduction IPSC= inhibitory post-synaptic current m = miniaturee = evoked

10 Methods Male C57B1/6J mice Decapitated mice and placed brain in ice- cold sucrose aCSF Slices 300um thick Rostral slices contained anterior BNST  Stored in heated, oxygenated container w/ aCSF  Transferred to submerged recording chamber Heated, O 2 aCSF for 1h ā experiments

11 Methods Slices in chamber and neurons of vlBNST visualized w/ infrared video microscopy Analyzed eIPSC & EPSC  Electrodes filled w/ pH 7.2  Twisted nichrome wire  Placed in vlBNST  Cells held @ -50mV & GABA A R-mediated IPSCs evoked @ 0.2 Hz by fiber stim w/ bipolar electrodes

12 Methods GABA A -IPSCs (& EPSC) isolated  3mM kynurenic acid (& 25uM picrotoxin) = block AMPA & NMDA receptor-dependent postsynaptic currents  1uM CGP 55845 = block GABA B R Signals acquired via Multiclamp 700B amplifier Input and series resistance continuously monitored

13 Methods eIPSC → measured peak amplitude of synaptic response normalized to baseline Baseline period = 2 min period immediately preceding drug  Value is 2 min avg 15 min p neuropeptide 0 3 5 10 15 20 22 B peptide *

14 Methods mIPSC analysis  GABA A R-mediated IPSCs isolated → added 0.5uM TTX  recorded in 120s episodes  Ca 2+ influx on NPY → 100uM Cd 2+ + aCSF  Amplitude and frequency determined from 120s recording w/ cells held @ -70mV Multi-clamp

15 Methods All drugs applied via bath All peptides used were dissolved in dH2O to 0.1mM conc  Some stored @ -20°C

16 Results NPY and CRF influence on inhibitory synaptic transmission in vlBNST  Whole-cell voltage clamp Local stimulation produced eIPSC from GABA A Rs  SR95531= GABA A R antagonist blocked response

17

18 Results TTX elicited spontaneous mIPSCs GABAzine = GABA A R antagonist  mIPSCs blocked  GABA A R mediated

19 Results NPY depresses GABA through Y2R Baseline recordings revealed decreased peak amplitude of eIPSC  Observed in all cells NPY-induced depression = concentration dependent

20

21 Results NPY13-36 = Y2R agonist  ↓ peak amplitude [Pro 34 ]-NPY = Y1R agonist & [D-Trp 32 ]-NPY = Y5R agonist  No change

22

23 Results Antagonist testing was preceded by an exposure to NPY (10-15min) Agonist and antagonist co-applied (5min) NONE had significant effects on eIPSC without agonist

24 Results Non-peptide Y2R antagonist blocked NPY actions Peptide Y1R antagonist had no effect Non-peptide Y5R antagonist had no effect Y2Rs activated NPY-induced eIPSC depression

25 Results Paired Pulse Ratio experiments  Pair of eIPSCs w/ 50ms between  Ratio of amplitudes determined NPY ↑ PPR of eIPSCs  Suggest ↓ release of GABA NPY ↓ frequency but not amplitude

26

27 Results Presynaptic inhibition of NT release  Modulate Ca 2+ entry  Regulate release machinery At CNS synapse basal mIPSC freq ↓ by using Cd 2+ to block Vg Ca 2+ channels Cd 2+ + NPY = restores mIPSCs NPY inhibits GABA via Y2R regulation of Ca 2+ influx

28 Results 5 min bath of 1um CRF sig ↑ peak amp of eIPSC 1um Urocortin (CRFR agonist) → similar results CRF results were concentration dependent [100nM vs 10nM] CRF antagonist had no sig effects on eIPSC in absence of agonist

29 Results Non-peptide CRFR1 antagonist (NBI 27914) blocked both CRF and Ucn I actions Peptide CRFR2 antagonist (anti- Sauvagine-30) had no sig effect Ucn I enhanced eIPSCs in CRFR2 knockout mice So, CRF/Ucn I induced enhancement of eIPSC is d/t CRFR1 activation

30

31 Results CRF  did not alter PPR or mIPSC kinetics  no effect on freq of mIPSCs  Mean amplitude ↑↑  Shifted cum. amplitude curve to the right CRF enhanced GABAergic postsynaptic transmission Change in IPSCs d/t non-specific enhancement via synaptic excitability

32 Discussion NPY suppresses GABAergic transmission in vlBNST via Y2R: 1.NPY effect mimicked by NPY13-36, not by [Pro 34 ]-NPY (Y1 agonist) or [D- Trp 32 ]-NPY (Y5 agonist) 2.NPY antagonized by Y2R antagonist (BIEE 0246), not by BVD-10 (Y1R antagonist) or L-152804 (Y5R antagonist)

33 Discussion Data consistent w/ NPY actions in thalamus & PVN and Y2R expression in BNST Y2R ↓ GABA release: 1.NPY ↑ PPR of eIPSCs → ↓ release probability 2.NPY ↓ mIPSC frequency not amplitude 3.Cd +2 effect → NPY via Y2R inhibit GABA via presynaptic Ca +2 influx

34 Discussion NPY via Y2R → heterocepter on GABAergic terminals Which YR is activated determines the behavioral outcome  Y1R and maybe Y5R → NPY anxiolytic response  Y2R → anxiogenic response But, Y2R activation in LC → NPY anxiolytic effects

35 Discussion Suppose region-specific activation of YR subtypes will evoke distinct behavioral phenotypes, OR… Autoreceptor-like functions are anxiolytic

36 Discussion Based on evidence that inhibitory projections from the vlBNST contact PVN neurons: ↓ GABAergic input to vlBNST → ↑ GABAergic output to PVN → ↓ stress response

37 Discussion In the vlBNST, CRF and Ucn I enhance GABAergic transmission via CRFR1: 1.CRF & Ucn I antagonized by NBI 27914 (CRFR1), not AS 30 (CRFR2) 2.Ucn I effects observed in mice lacking CRFR2 3.CRFR1 enhance postsynaptic GABA A -R response

38 Discussion CRF ↑ mIPSC amplitude not frequency or PPR Glutamatergic transmission in vlBNST not affected by Ucn I Presynaptic CRFR1 mediates GABAergic transmission in CeA Altering mIPSC frequency modulates GABA release → now amplitude as well

39 Discussion CRFR1 mediates CRF anxiogenic effects in the BNST CRF enhancing GABAergic transmission in BNST could potentially reactivate the PVN → stress response


Download ppt "Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis."

Similar presentations


Ads by Google